InfuSystem Holdings, Inc. (INFU) is a publicly traded Healthcare sector company. As of July 28, 2026, INFU trades at $9.35 with a market cap of $184.06M and a P/E ratio of 24.84. INFU moved -0.10% today. Year to date, INFU is +4.35%; over the trailing twelve months it is +55.74%. Its 52-week range spans $4.61 to $11.04. Analyst consensus is buy with an average price target of $17.50. Rallies surfaces INFU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for INFU combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $9.35 |
| Market Cap | $184.06M |
| P/E Ratio | 24.84 |
| EPS | $0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.04 |
| 52-Week Low | $4.61 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $142.40M |
| Net Income | $7.91M |
| Gross Margin | 56.75% |
2 analysts cover INFU: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.50.